View abstract

Cet abstract a été assigné à session AOB: Academia Ophthalmologica Belgica
TitreThe use of Iridium Brachytherapy in multifocal and non-limbal conjunctival melanoma
Abstract Nr.1026
ButTo describe technique, possibilities and outcome for Iridium brachytherapy in conjunctival melanoma. As data show that irradiation decreases the number of recurrences and has a trend to give better survival in conjunctival melanomas, iridium brachytherapy was used as adjuvant therapy in difficult cases.
MéthodesDescription of seven patients with conjunctival melanoma.
RésultatsIn seven patients with non-limbal conjunctival melanoma, iridium needles were used to apply irradiation of the tumor beds. A mean follow-up of 3 years was found. No recurrences were detected. One patient died due to his melanoma within 2 years after treatment of the primary tumor. In one patient a scleral thinning was found. All patients have transient dry eye syndrome, and (temporal) loss of eye lashes. None of the patients show irradiation retinopathy or cataract within the follow-up period. In one patient the treatment could be safely combined with strontium plaque therapy for a large perilimbal component.
ConclusionIridium brachytherapy is a safe adjuvant procedure for the treatment of extended and multifocal non-limbal conjunctival melanomas, which gives good local control.
Auteur 1
NomMISSOTTEN
InitialesG
InstitutKatholieke Universiteit Leuven
VilleLeuven
Auteur 2
NomVan Limbergen
InitialesE
InstitutKatholieke Universiteit Leuven
VilleLeuven
Auteur 3
NomSpileers
InitialesW
InstitutKatholieke Universiteit Leuven
VilleLeuven
top ^